Molnar-Institute - Pharma Technology Focus | Issue 151 | February 2025

DryLab^®4: Empower™ Automated.

One-Click Batch Creation. Enhanced Modeling Performance

The 4-Step Design Space Modeling Workflow

Waters Empower™ + Instrumentation

Waters Empower™ + Instrumentation

Design Space Modeling in 4 Simple Steps

Empower Automated

DryLab. Chromatographic Retention Modeling since 1986

02/12/2025 17:19:09

Home | The biggest challenges clinical trials will face in 2025
Editor's letter
Contents
Mimotopes Company Insight
Mimotopes
Briefing
News in Numbers
Latest News
Latest Deals
Molnar-Institute Company Insight
Molnar-Institute
In Depth
The biggest challenges clinical trials will face in 2025
Investors optimistic about continued biotech and medtech IPO resurgence in 2025
ADCs breach barriers to become mainstream cancer treatment
WHO trial guidance goes beyond race and gender when tackling diversity
Mega M&A at JP Morgan Conference 2025 — is biopharma M&A poised for a rebound?
From Davids to Goliaths: the GLP-1RA gold rush
Radiopharmaceutical trials face extra complexities due to nuclear red tape
PCI Pharma Services
Endress+Hauser
Listings
Events
Event: Digital Health Festival 2025
Pharmaceutical Technology Excellence Awards 2024 winners
Buyer's Guides
Next issue

01/22/2025 00:00:00